A Score Based on NfL and Glial Markers May Differentiate Between Relapsing–Remitting and Progressive MS Course

Background: The diagnostic use of biomarkers in body fluids of multiple sclerosis (MS) patients allows the monitoring of different pathophysiological aspects of the disease. We previously reported elevated cerebrospinal fluid (CSF) and serum levels of glial fibrillary acidic protein (GFAP) but not n...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Neurol
Asıl Yazarlar: Huss, André, Otto, Markus, Senel, Makbule, Ludolph, Albert C., Abdelhak, Ahmed, Tumani, Hayrettin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2020
Konular:
Neurology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378743/
https://ncbi.nlm.nih.gov/pubmed/32765393
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.00608
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller